Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Programa iParent2Parent para pais de receptores de transplante de órgãos sólidos pediátricos

16 de novembro de 2026 atualizado por: Samantha Anthony, The Hospital for Sick Children

"O isolamento que sinto é profundo": o programa de apoio on-line iParent2Parent para pais de receptores de transplante de órgãos sólidos pediátricos

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.

Visão geral do estudo

Status

Recrutamento

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

55

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • Ontario
      • Toronto, Ontario, Canadá, M5G 1X8
        • Recrutamento
        • Hospital for Sick Children
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 75 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Mentee Inclusion Criteria:

  • Parent of a patient under 18 years of age who received a solid organ transplant and is at least two months post-transplant,
  • Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and
  • English-speaking.

Mentor Inclusion Criteria:

  • Parent of a patient under 21 years of age who received a solid organ transplant and is at least one year post-transplant,
  • Nominated by their child's healthcare team as a good candidate to act in the mentor role (e.g., good communication skills, positive adaptation and adjustment post-transplant, strong support network),
  • Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and
  • English-speaking.

Exclusion Criteria:

  • Non-English speaking.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Grupo de controle de lista de espera padrão de atendimento
Experimental: Programa iParent2Parent

iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Adherence with the iParent2Parent program
Prazo: Baseline to study completion, an average of 1 year

When the participant completes 10 audio or video calls over 12 weeks and 100% when all online outcome measures completed.

Baseline to study completion, an average of 1 year
Acceptability (Mentees)
Prazo: Baseline to 12 weeks after baseline/immediately after the intervention

Whether the innovation is agreeable, palatable or satisfactory.

Measured via semi-structured interview or focus group.

Baseline to 12 weeks after baseline/immediately after the intervention
Acceptability (Mentors)
Prazo: Baseline to program completion, an average of one year

Whether the innovation is agreeable, palatable or satisfactory.

Measured via semi-structured interview or focus group.

Baseline to program completion, an average of one year
Level of engagement with the iParent2Parent program (Mentees)
Prazo: Baseline to 12 weeks after baseline/immediately after the intervention

Measured via semi-structured interview or focus group.

Baseline to 12 weeks after baseline/immediately after the intervention
Level of engagement with the iParent2Parent program (Mentors)
Prazo: Baseline to program completion, an average of one year

Measured via semi-structured interview or focus group.

Baseline to program completion, an average of one year
Barriers and enablers of the iParent2Parent program (Mentees)
Prazo: Baseline to 12 weeks after baseline/immediately after the intervention

Measured via semi-structured interview or focus group.

Baseline to 12 weeks after baseline/immediately after the intervention
Barriers and enablers of the iParent2Parent program (Mentors)
Prazo: Baseline to program completion, an average of one year

Measured via semi-structured interview or focus group.

Baseline to program completion, an average of one year
Recruitment rates and withdrawal rates
Prazo: Baseline to study completion, an average of 1 year

How many participants were recruited and have withdrawn from the program on average over time.

Baseline to study completion, an average of 1 year

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Parenting stress (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Parental Stress Scale; 18-item questionnaire. Each question is scored on a scale from 1 to 5, with scores ranging from 18 to 90. An overall higher score means a worse outcome.

Baseline to program completion, an average of one year
Psychological distress (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

General Anxiety Disorder-7; 7-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 21. An overall higher score means a worse outcome.

Baseline to program completion, an average of one year
Psychological distress (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Patient Health Questionnaire Depression Scale; 8-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 24. An overall higher score means a worse outcome.

Baseline to program completion, an average of one year
Perceived social support (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Short form version 2.0 of the PROMIS battery for: Social Isolation; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a worse outcome.

Baseline to program completion, an average of one year
Perceived social support (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Short form version 2.0 of the PROMIS battery for: Informational Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome.

Baseline to program completion, an average of one year
Perceived social support (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Short form version 2.0 of the PROMIS battery for: Emotional Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome.

Baseline to program completion, an average of one year
Coping (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Coping Health Inventory for Parents; 16-item questionnaire. Each question about coping behaviour is scored on a scale from 0 to 3, with a possible response of "Did not use" the coping behaviour. Scores range from 0 to 48. An overall higher score means a better outcome.

Baseline to program completion, an average of one year
Family Functioning (Mentees and Mentors)
Prazo: Baseline to program completion, an average of one year

Pediatric Quality of Life Inventory™ 2.0 Family Impact Module; 36-item questionnaire with 8 different sections: Physical Functioning, Emotional Functioning, Social Functioning, Cognitive Functioning, Communication, Worry, Daily Activities, and Family Relationships. Each question is scored on a scale from 0 to 4. Items are reverse-scored and linearly transformed to a 0-100 scale. An overall higher score means a better outcome.

Baseline to program completion, an average of one year

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Samantha J. Anthony, PhD, MSW, The Hospital for Sick Children

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de agosto de 2023

Conclusão Primária (Real)

26 de junho de 2026

Conclusão do estudo (Estimado)

31 de março de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

29 de junho de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

28 de julho de 2023

Primeira postagem (Real)

1 de agosto de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

19 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 1000080779

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever